Skip to content

A Study of the Relief of Tooth Sensitivity of an Experimental Mouthrinse Device

Assessment of a Potassium Oxalate-Containing Formulation for the Relief of Dentinal Hypersensitivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01345292
Enrollment
226
Registered
2011-05-02
Start date
2011-04-30
Completion date
2011-05-31
Last updated
2015-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin Sensitivity

Brief summary

This study is for people with sensitive teeth and involves going to the dentist for 4 visits over 6 weeks. During the first 2 weeks, you will just brush your teeth two times a day with the fluoride toothpaste provided. Then you will be assigned to a group if you qualify to continue in the study. All groups will get a marketed toothpaste and one group will also get a mouthwash with an experimental ingredient. You will have an equal chance of being assigned to any one of the three groups. For the next 4 weeks, you will brush with your assigned toothpaste and rinse with your assigned mouthwash if assigned to the mouthwash group. A dentist will look at your mouth, teeth, tongue and gums and check for sensitive teeth. The investigators will see if the mouthwash helps to reduce tooth sensitivity during the study.

Detailed description

This is an observer-blind, randomized, parallel-group, single-center, controlled clinical trial. Approximately 246 generally healthy adults meeting the necessary inclusion/exclusion criteria will be enrolled so that 210 subjects (70 per group) would reasonably be expected to complete the study. Subjects will have their oral soft/hard tissues assessed and will be evaluated for sensitivity levels at Screening (Visit 1), Baseline (Visit 2), Visit 3 at Week 2 and Visit 4 at Week 4. During the first two weeks of the study, subjects will be instructed to brush their teeth for one minute in their usual manner, twice daily, using the provided standard fluoride toothpaste. Subjects will return for the Baseline exam and, upon qualification with entry criteria, will be assigned to one of three treatment groups. Qualified subjects will be instructed to brush their teeth two times daily for one minute in their usual manner using the provided toothpaste (standard fluoride toothpaste or 5% potassium nitrate toothpaste). Subjects assigned to the mouthrinse group will be instructed to rinse twice daily, after brushing, with the provided mouthrinse for 60 seconds using 10 ml, for 4 consecutive weeks.

Interventions

DEVICEMouthwash

Rinse with 10 ml of the assigned mouthwash for 60 seconds after you brush in your usual manner twice daily for one minute using at least a one-inch strip of the assigned toothpaste

Brush in your usual manner twice daily for at least one minute using at least a one-inch strip of the assigned toothpaste

Brush in your usual manner twice daily for at least one minute using at least a one-inch strip of the assigned toothpaste

Sponsors

Johnson & Johnson Consumer and Personal Products Worldwide
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females at least 18 years of age in good general and oral health without any known allergy to commercial dental products or cosmetics. * Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial. * Willingness to use the assigned products according to instructions, availability for appointments, and likelihood of completing the clinical trial. * The appropriate number and location of eligible teeth, based on protocol-defined standards. * Adequate oral hygiene (i.e., brush teeth daily and exhibit no signs of oral neglect).

Exclusion criteria

* Any medical or dental history or condition, or use of any medication or drug, that per protocol or in the opinion of the investigator might compromise subject comfort or safety, or the analysis of study results. * Volunteers who have been using any of the following within protocol-defined timeframes: * home-care bleaching, whitening products or professional bleaching treatment * desensitizing agents whether prescribed or over-the-counter * sensitivity toothpastes, mouthwash or oral care products used for the treatment of dentinal hypersensitivity * Women who are pregnant, nursing or plan to become pregnant during the course of the study.

Design outcomes

Primary

MeasureTime frameDescription
Mean Tactile Sensitivity Score at Week 44 weeksTooth sensitivity was measured using a Yeaple probe. The force at which discomfort was felt by the participant was recorded on a scale of 10-80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.
Mean Tactile Sensitivity Score at Week 22 weeksTooth sensitivity was measured using a Yeaple probe. The force at which discomfort was felt by the participant was recorded on a scale of 10-80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Secondary

MeasureTime frameDescription
Mean Cold Air Stimulus VAS Score at Week 22 weeksTooth sensitivity was measured using a Cold Air Stimulus. When being assessed, participants rated their perception of the pain/discomfort experienced when cold air was directed at the exposed root of each tooth by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The score for each participant was calculated by averaging the scores for all study teeth for that participant.
Mean Cold Air Stimulus VAS Score at Week 44 weeksTooth sensitivity was measured using a Cold Air Stimulus. When being assessed, participants rated their perception of the pain/discomfort experienced when cold air was directed at the exposed root of each tooth by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The score for each participant was calculated by averaging the scores for all study teeth for that participant.
Mean Tactile Sensitivity Visual Analog Scale (VAS) Score at Week 22 weeksTooth sensitivity was measured using a VAS. At each visit, participants rated their perception of the pain/discomfort experienced from the Yeaple probe by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The investigator recorded a VAS score of 0 mm for participants who did not experience discomfort at the maximum force of 80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.
Global Subjective VAS Score at Week 44 weeksAt each visit, participants rated their perception of the pain/discomfort experienced by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. Participants were instructed as follows: Please rate the intensity of the pain/discomfort you have experienced in the last two weeks when drinking cold/hot beverages and/or foods, eating sweet and sour foods, breathing cold air, brushing your teeth or performing any habits/behaviors that solicit your dentinal hypersensitivity pain/discomfort since you first started using the product. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm.
Global Subjective VAS Score at Week 22 weeksAt each visit, participants rated their perception of the pain/discomfort experienced by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. Participants were instructed as follows: Please rate the intensity of the pain/discomfort you have experienced in the last two weeks when drinking cold/hot beverages and/or foods, eating sweet and sour foods, breathing cold air, brushing your teeth or performing any habits/behaviors that solicit your dentinal hypersensitivity pain/discomfort since you first started using the product. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm.
Mean Tactile Sensitivity VAS Score at Week 44 weeksTooth sensitivity was measured using a VAS. At each visit, participants rated their perception of the pain/discomfort experienced from the Yeaple probe by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The investigator recorded a VAS score of 0 mm for participants who did not experience discomfort at the maximum force of 80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Countries

United States

Participant flow

Participants by arm

ArmCount
Negative Control (Crest Regular Toothpaste)
Crest® Cavity Protection Regular Toothpaste (Brushing Only)
75
Positive Control (Sensodyne Toothpaste)
Sensodyne® Original Toothpaste (Brushing Only)
76
12027-027 (1.40% Potassium Oxalate Mouth Rinse)
Crest® Cavity Protection Regular Toothpaste followed by Investigative 1.40% Potassium Oxalate Mouth Rinse (Brushing followed by Mouth Rinse)
75
Total226

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyWithdrawal by Subject201

Baseline characteristics

CharacteristicNegative Control (Crest Regular Toothpaste)Positive Control (Sensodyne Toothpaste)12027-027 (1.40% Potassium Oxalate Mouth Rinse)Total
Age, Continuous35.6 years
STANDARD_DEVIATION 10.65
35.8 years
STANDARD_DEVIATION 12.14
37.4 years
STANDARD_DEVIATION 11.1
36.3 years
STANDARD_DEVIATION 11.3
Region of Enrollment
USA
75 participants76 participants75 participants226 participants
Sex: Female, Male
Female
51 Participants52 Participants50 Participants153 Participants
Sex: Female, Male
Male
24 Participants24 Participants25 Participants73 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 750 / 760 / 75
serious
Total, serious adverse events
0 / 750 / 760 / 75

Outcome results

Primary

Mean Tactile Sensitivity Score at Week 2

Tooth sensitivity was measured using a Yeaple probe. The force at which discomfort was felt by the participant was recorded on a scale of 10-80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Time frame: 2 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Mean Tactile Sensitivity Score at Week 210.10 grams of forceStandard Error 0.576
Positive Control (Sensodyne Toothpaste)Mean Tactile Sensitivity Score at Week 213.16 grams of forceStandard Error 0.571
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Mean Tactile Sensitivity Score at Week 212.51 grams of forceStandard Error 0.579
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [1.45, 4.65]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.00495% CI: [0.8, 4.02]ANCOVA
Primary

Mean Tactile Sensitivity Score at Week 4

Tooth sensitivity was measured using a Yeaple probe. The force at which discomfort was felt by the participant was recorded on a scale of 10-80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Time frame: 4 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Mean Tactile Sensitivity Score at Week 410.39 grams of forceStandard Error 1.111
Positive Control (Sensodyne Toothpaste)Mean Tactile Sensitivity Score at Week 421.83 grams of forceStandard Error 1.086
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Mean Tactile Sensitivity Score at Week 418.72 grams of forceStandard Error 1.101
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [8.37, 14.5]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [5.24, 11.42]ANCOVA
Secondary

Global Subjective VAS Score at Week 2

At each visit, participants rated their perception of the pain/discomfort experienced by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. Participants were instructed as follows: Please rate the intensity of the pain/discomfort you have experienced in the last two weeks when drinking cold/hot beverages and/or foods, eating sweet and sour foods, breathing cold air, brushing your teeth or performing any habits/behaviors that solicit your dentinal hypersensitivity pain/discomfort since you first started using the product. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm.

Time frame: 2 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Global Subjective VAS Score at Week 244.94 units on a scale (mm)Standard Error 1.426
Positive Control (Sensodyne Toothpaste)Global Subjective VAS Score at Week 243.68 units on a scale (mm)Standard Error 1.416
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Global Subjective VAS Score at Week 243.64 units on a scale (mm)Standard Error 1.434
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.53395% CI: [-5.22, 2.71]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.52295% CI: [-5.29, 2.69]ANCOVA
Secondary

Global Subjective VAS Score at Week 4

At each visit, participants rated their perception of the pain/discomfort experienced by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. Participants were instructed as follows: Please rate the intensity of the pain/discomfort you have experienced in the last two weeks when drinking cold/hot beverages and/or foods, eating sweet and sour foods, breathing cold air, brushing your teeth or performing any habits/behaviors that solicit your dentinal hypersensitivity pain/discomfort since you first started using the product. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm.

Time frame: 4 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Global Subjective VAS Score at Week 441.32 units on a scale (mm)Standard Error 1.664
Positive Control (Sensodyne Toothpaste)Global Subjective VAS Score at Week 432.79 units on a scale (mm)Standard Error 1.63
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Global Subjective VAS Score at Week 435.19 units on a scale (mm)Standard Error 1.651
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [-13.1, -3.94]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.0195% CI: [-10.8, -1.51]ANCOVA
Secondary

Mean Cold Air Stimulus VAS Score at Week 2

Tooth sensitivity was measured using a Cold Air Stimulus. When being assessed, participants rated their perception of the pain/discomfort experienced when cold air was directed at the exposed root of each tooth by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Time frame: 2 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Mean Cold Air Stimulus VAS Score at Week 243.65 units on a scale (mm)Standard Error 1.612
Positive Control (Sensodyne Toothpaste)Mean Cold Air Stimulus VAS Score at Week 238.74 units on a scale (mm)Standard Error 1.6
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Mean Cold Air Stimulus VAS Score at Week 240.22 units on a scale (mm)Standard Error 1.623
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.03295% CI: [-9.38, -0.43]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.13695% CI: [-7.93, 1.09]ANCOVA
Secondary

Mean Cold Air Stimulus VAS Score at Week 4

Tooth sensitivity was measured using a Cold Air Stimulus. When being assessed, participants rated their perception of the pain/discomfort experienced when cold air was directed at the exposed root of each tooth by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Time frame: 4 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Mean Cold Air Stimulus VAS Score at Week 439.54 units on a scale (mm)Standard Error 1.792
Positive Control (Sensodyne Toothpaste)Mean Cold Air Stimulus VAS Score at Week 428.36 units on a scale (mm)Standard Error 1.755
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Mean Cold Air Stimulus VAS Score at Week 429.30 units on a scale (mm)Standard Error 1.78
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [-16.1, -6.23]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [-15.2, -5.25]ANCOVA
Secondary

Mean Tactile Sensitivity VAS Score at Week 4

Tooth sensitivity was measured using a VAS. At each visit, participants rated their perception of the pain/discomfort experienced from the Yeaple probe by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The investigator recorded a VAS score of 0 mm for participants who did not experience discomfort at the maximum force of 80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Time frame: 4 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Mean Tactile Sensitivity VAS Score at Week 439.49 units on a scale (mm)Standard Error 1.815
Positive Control (Sensodyne Toothpaste)Mean Tactile Sensitivity VAS Score at Week 430.94 units on a scale (mm)Standard Error 1.782
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Mean Tactile Sensitivity VAS Score at Week 429.32 units on a scale (mm)Standard Error 1.799
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [-13.6, -3.52]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: <0.00195% CI: [-15.2, -5.13]ANCOVA
Secondary

Mean Tactile Sensitivity Visual Analog Scale (VAS) Score at Week 2

Tooth sensitivity was measured using a VAS. At each visit, participants rated their perception of the pain/discomfort experienced from the Yeaple probe by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The investigator recorded a VAS score of 0 mm for participants who did not experience discomfort at the maximum force of 80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant.

Time frame: 2 weeks

Population: Analysis was based on the Intent-to-Treat (ITT) analysis set, defined as all randomized participants who used at least one dose of the study product and had baseline and at least one post-baseline efficacy assessment.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Negative Control (Crest Regular Toothpaste)Mean Tactile Sensitivity Visual Analog Scale (VAS) Score at Week 241.59 units on a scale (mm)Standard Error 1.478
Positive Control (Sensodyne Toothpaste)Mean Tactile Sensitivity Visual Analog Scale (VAS) Score at Week 239.52 units on a scale (mm)Standard Error 1.471
12027-027 (1.40% Potassium Oxalate Mouth Rinse)Mean Tactile Sensitivity Visual Analog Scale (VAS) Score at Week 237.16 units on a scale (mm)Standard Error 1.485
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.32495% CI: [-6.19, 2.06]ANCOVA
Comparison: The null hypothesis was no difference in mean outcome between treatment groups. The alternative hypothesis was a difference in mean outcome between treatment groups.p-value: 0.03595% CI: [-8.56, -0.31]ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026